SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Truist Raises Hinge Health Price Target to $145, Keeps Buy Rating

Truist raised its price target on Hinge Health to $145 from $112 and maintained a Buy rating.

HNGE

Related stories